Correlation between molecular prognostic factors and bevacizumab therapeutic resistance in patients with metastatic colorectal cancer; the AVAMET study
Objectives. Colorectal cancer is responsible for more than two million cases diagnosed annually. Despite early diagnosis through screening programs and adequate treatment, 25% of cases are diagnosed with metastatic disease while up to 50% of patients diagnosed early progress to metastatic disease. M...
Saved in:
| Main Authors: | Adrian Paul Suceveanu, Dragos Serban, Andreea Daniela Caloian, Georgeta Camelia Cozaru, Anca Chisoi, Anca Antonela Nicolau, Ioan Sergiu Micu, Andra Iulia Suceveanu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-04-01
|
| Series: | Journal of Mind and Medical Sciences |
| Subjects: | |
| Online Access: | https://scholar.valpo.edu/cgi/viewcontent.cgi?article=1477&context=jmms |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Subconjunctival injection of bevacizumab for treatment of pterygium
by: Anthony F. Felipe, MD, et al.
Published: (2009-12-01) -
Intravitreal Bevacizumab as Adjunctive Therapy for Bleb Survival in Trabeculectomy in Rabbit Eyes
by: Margarita Echavez, MD, et al.
Published: (2012-06-01) -
Role of Anti VEGF Agent in Management of Primary Pterygium
by: Abhinav Singh, et al.
Published: (2018-10-01) -
Vascular endothelial growth factor facilitates the effects of telocytes on tumor cell proliferation and migration
by: Fujie Li, et al.
Published: (2024-11-01) -
Comparative analysis of bevacizumab and sorafenib on the survival of retinal ganglion cells in the treatment of retinal diseases
by: Wungrak Choi, et al.
Published: (2025-08-01)